GlassScriptPhysician profile
Steven Michael Pisano
NPI 1528069655
$2,088.59
in general payments reported to CMS, 2019-2025
9 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $108 · 2023: $309 · 2024: $1,055 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,815.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,073.59 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $372.49 | 2024-2025 | Irrisept |
| Mentor Worldwide LLC | $173.12 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $148.98 | 2025 | |
| Abbvie INC. | $145.79 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $94.38 | 2024-2025 | |
| Integra Lifesciences Corporation | $32.99 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Stryker Corporation | $30.70 | 2025 | Colorado, Medpor |
| Davol INC. | $16.55 | 2023 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pisano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.